MAG

Chr 19AR

myelin associated glycoprotein

Also known as: GMA, S-MAG, SIGLEC-4A, SIGLEC4, SIGLEC4A, SPG75

The protein encoded by this gene is a type I membrane protein and member of the immunoglobulin superfamily. It is thought to be involved in the process of myelination. It is a lectin that binds to sialylated glycoconjugates and mediates certain myelin-neuron cell-cell interactions. Three alternatively spliced transcripts encoding different isoforms have been described for this gene. [provided by RefSeq, Nov 2010]

OMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 0.421 OMIM phenotype
Clinical SummaryMAG
🧬
Gene-Disease Validity (ClinGen)
complex hereditary spastic paraplegia · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.21) despite low pLI — interpret in context.
📋
ClinVar Variants
16 unique Pathogenic / Likely Pathogenic· 179 VUS of 372 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.42LOEUF
pLI 0.492
Z-score 3.84
OE 0.21 (0.120.42)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.13Z-score
OE missense 0.84 (0.770.92)
348 obs / 412.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.21 (0.120.42)
00.351.4
Missense OE?0.84 (0.770.92)
00.61.4
Synonymous OE?0.98
01.21.6
LoF obs/exp: 6 / 27.9Missense obs/exp: 348 / 412.9Syn Z: 0.18

This gene — mechanism propensity

DN
0.6455th %ile
GOF
0.6638th %ile
LOF
0.3746th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function, gain-of-function and dominant-negative). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF69% of P/LP variants are LoF · LOEUF 0.42
GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

372 submitted variants in ClinVar

Classification Summary

Pathogenic8
Likely Pathogenic8
VUS179
Likely Benign147
Benign21
Conflicting6
8
Pathogenic
8
Likely Pathogenic
179
VUS
147
Likely Benign
21
Benign
6
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
5
3
0
0
8
Likely Pathogenic
6
1
1
0
8
VUS
1
172
5
1
179
Likely Benign
0
7
33
107
147
Benign
0
3
10
8
21
Conflicting
6
Total1218649116369

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

17 pathogenic / likely-pathogenic (of 21) ClinVar copy-number / structural variants overlap MAG — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

MAG · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.